Thermo Fisher Scientific (TMO): One of the Best Diabetes Stocks to Buy According to Billionaires
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...
Central Lab Services Market worth US$8.18 billion by 2030with 6.5% CAGR | MarketsandMarkets
The global Central Lab Services/Clinical Trial Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR ...
Le Lézard12h
SiMa.ai Recognized on Fast Company's Annual List of the World's Most Innovative Companies for 2025
SiMa.ai, the software-centric, embedded edge machine learning system-on-chip (MLSoC) company, has been named to Fast Company's prestigious list of the world's Most Innovative Companies for 2025.
Global Softgel Capsules Market Projected to Grow at a CAGR of 7.7%
According to the latest study from BCC Research, "Softgel Capsules: Global Markets" is expected to grow from $7.9 billion in 2024 to ...
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market
The stock's rise snapped a four-day losing streak.
Biotech Boom: Cell-Based Assays Revolutionizing Drug Development & Precision Medicine
The Cell-Based Assays Market is projected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, at a 9.8% CAGR, driven by demand for drug discovery, ADME/toxicity testing, and precision ...
Clinical Trial Services Market worth US$101.86 billion by 2030 with 8.9% CAGR | MarketsandMarkets™
The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9% ...